Clinical Trial Update: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of KHK4951 in diabetic macular edema is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• KHK4951

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Diabetic Macular Edema (DME) | Phase 2 | Status: ACTIVE_NOT_RECRUITING